Reliance Life Sciences Private Limited: Bortezomib For Injection 3.5mg/vial
Recall Summary Bortezomib for Injection 3.5mg/Vial (a cancer medication manufactured by Reliance Life Sciences for Somerset Therapeutics) is being recalled nationwide because it lacks sterility assurance, meaning the product may not be free from contamination. This is a Class II recall, indicating a potential health hazard. The recall affects all U.S. states and the District of Columbia.
- Recalling firm
- Reliance Life Sciences Private Limited
- Product
- Bortezomib for Injection 3.5mg/Vial, 10 mL per Single-Dose Vial, For Intravenous or Subcutaneous Use, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873. NDC: 70069-0836-01
- Reason
- Lack of Sterility Assurance
- Classification
- Class II
- Category
- drug recall
- Country
- United States
- Agency
- U.S. Food and Drug Administration
- Recall date
- 2026-06-24
- Status
- Ongoing
- Areas affected
- AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...
- Distribution
- Nationwide in the USA
Official recall notice from U.S. Food and Drug Administration
Recall details on Nibble Recalls: https://trynibble.app/recalls/faf2ecce-c24c-47cb-a47d-98c802717680